Sanofi (SNY) Amortization - Intangibles (2009 - 2026)

Sanofi (SNY) has 18 years of Amortization - Intangibles data on file, last reported at -$626.3 million in Q1 2026.

• Quarterly Amortization - Intangibles fell 49.24% year-over-year to -$626.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.6 billion (down 43.91% YoY) and the FY2025 annual result came in at $2.1 billion, up 10.61% from the prior year.
• Amortization - Intangibles grew to -$626.3 million in Q1 2026 per SNY's latest filing, from -$2.1 billion in the prior quarter.
• The five-year high for Amortization - Intangibles was -$419.7 million in Q1 2025, with the low at -$2.1 billion in Q4 2022.
• Average Amortization - Intangibles over 5 years is -$931.7 million, with a median of -$594.6 million recorded in 2023.
• Year-over-year, Amortization - Intangibles plunged 335.94% in 2022 and rose 28.02% in 2024.
• Sanofi's Amortization - Intangibles stood at -$2.1 billion in 2022, then climbed by 1.84% to -$2.1 billion in 2023, then advanced by 9.1% to -$1.9 billion in 2024, then fell by 10.61% to -$2.1 billion in 2025, then soared by 69.7% to -$626.3 million in 2026.
• Business Quant data shows SNY's Amortization - Intangibles at -$626.3 million in Q1 2026, -$2.1 billion in Q4 2025, and -$1.4 billion in Q3 2025.